Media release, October 23, 2014 Stopping anti-CCL2 breast cancer treatment aggravates the disease Mohamed Bentires-Alj and his team at the Friedrich Miescher Institute for Biomedical Research (FMI) together with scienti

First Page		Document Content
Date: 2014-10-22 09:52:50 Health Medicine Clinical medicine Ribbon symbolism RTT Breast cancer Metastatic breast cancer CCL2 Friedrich Miescher Institute for Biomedical Research Metastasis Tumor microenvironment Angiogenesis		Media release, October 23, 2014 Stopping anti-CCL2 breast cancer treatment aggravates the disease Mohamed Bentires-Alj and his team at the Friedrich Miescher Institute for Biomedical Research (FMI) together with scienti Add to Reading List Source URL: www.fmi.ch Download Document from Source Website File Size: 30,16 KB Share Document on Facebook

	Media release, October 23, 2014 Stopping anti-CCL2 breast cancer treatment aggravates the disease Mohamed Bentires-Alj and his team at the Friedrich Miescher Institute for Biomedical Research (FMI) together with scienti DocID: 1rf3r - View Document
	PowerPoint-Präsentation - Folie 1 DocID: 1oO6J - View Document
	Annual Meeting 2012 of the Basel Stem Cell Network (BSCN) April 13, 2012, Friday at 3:00-6:00 pm Friedrich Miescher Institute for Biomedical Research (FMI) Lecture Hall 5.30, 5th floor. Maulbeerstrasse 66, Basel. DocID: 1m5ge - View Document
	Christel GENOUD Friedrich Miescher Institute for Biomedical Research (FMI) Basel, Switzerland Website: http://www.fmi.ch/ Talk title: coming soon DocID: 1fJoe - View Document
	PROGRAM BIO POLICY SUMMIT DocID: 1fsPa - View Document